Update on the treatment of diabetic foot infections

Clin Podiatr Med Surg. 2007 Jul;24(3):383-96, vii. doi: 10.1016/j.cpm.2007.03.009.

Abstract

This article brings the practicing clinician up to date on the current concepts regarding the medical treatment of diabetic foot infections. Topics include a review of the Infectious Diseases Society of America Practice Guidelines for the Diagnosis and Treatment of Diabetic Foot Infections and a discussion of newer antibiotics such as linezolid, ertapenem, moxifloxacin, dalbavancin, tigecycline, ceftobiprole and iclaprim.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / etiology
  • Diabetic Foot / complications
  • Diabetic Foot / drug therapy*
  • Diabetic Foot / microbiology
  • Humans
  • Methicillin Resistance
  • Osteomyelitis / complications
  • Osteomyelitis / drug therapy
  • Osteomyelitis / microbiology
  • Practice Guidelines as Topic
  • Pseudomonas aeruginosa / drug effects
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / etiology
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents